^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

VLX1570

i
Other names: VLX1570, VLX 1570
Associations
Trials
Company:
Vivolux
Drug class:
UCHL5 inhibitor, USP14 inhibitor
Associations
Trials
2d
Ubiquitin-dependent recruitment of SLFN11 to chromatin is regulated by deubiquitinase (DUB) and RNF168. (PubMed, bioRxiv)
DUB inhibitors such as VLX-1570 promote ubiquitin-dependent enrichment of SLFN11 without detectable DNA damage, distinct from the camptothecin-induced RPA-associated SLFN11 foci formed at stressed replication forks. Yet, SLFN11 chromatin recruitment both by DUB inhibitors and DNA damage are suppressed by TAK243 demonstrating their ubiquitylation dependency. RNF168 is required for SLFN11 ubiquitylation and its subsequent chromatin association, and ubiquitylation within SLFN11's middle linker domain (lysines 390, 391, and 429) with K27-linked polyubiquitin chains is essential for the chromatin recruitment of SLFN11. These findings suggest the importance of SLFN11 ubiquitylation by RNF168 for SLFN11 chromatin recruitment and SLFN11 transcriptional regulatory role at promoter regions.
Journal
|
SLFN11 (Schlafen Family Member 11) • RNF168 (Ring Finger Protein 168)
|
TAK-243 • VLX1570
2years
A carboxy-terminal ubiquitylation site regulates androgen receptor activity. (PubMed, Commun Biol)
An inhibitor (VLX1570) of the deubiquitylases associated with the proteasome did not increase ubiquitylation of unliganded AR, indicating that AR is not targeted by these deubiquitylases...Mutagenesis of K313, in combination with K318, increases AR transcriptional activity, indicating that distinct posttranslational modifications at K313 differentially regulate AR activity. Together these studies expand the spectrum of AR posttranslational modifications, and indicate that the K911 site may regulate AR turnover on chromatin.
Journal
|
AR (Androgen receptor)
|
VLX1570
over4years
VLX1570 regulates the proliferation and apoptosis of human lung cancer cells through modulating ER stress and the AKT pathway. (PubMed, J Cell Mol Med)
Moreover, combined treatment with VLX1570 and Afatinib or Gefitinib induced synergistic anti-lung cancer activity. Our present study demonstrated a novel therapy using VLX1570, which inhibited the proliferation and increased apoptosis in human lung cancer.
Journal
|
ATF6 (Activating Transcription Factor 6) • CDK1 (Cyclin-dependent kinase 1) • ERN1 (Endoplasmic Reticulum To Nucleus Signaling 1) • CCNB1 (Cyclin B1)
|
Gilotrif (afatinib) • gefitinib • VLX1570
over4years
VLX1570 induces apoptosis through the generation of ROS and induction of ER stress on leukemia cell lines. (PubMed, Cancer Sci)
VLX1570 increased the amount of high molecular weight polyubiquitinated proteins and the expression of HSP70 as the result of the suppression of ubiquitine proteasome system, the expression of heme oxygenase-1 and the amount of phosphorylation in JNK and p38 associated with the generation of reactive oxygen species (ROS) induced apoptosis and the amount of phosphorylation in eIF2α, inducing the expression of ATF4 and endoplasmic reticulum (ER) stress dependent apoptosis protein, CHOP and the amount of phosphorylation slightly in IRE1α, leading to increased expression of XBP-1s in leukemia cell lines. In the present study, we demonstrate that VLX1570 induces apoptosis and exerts a potential anti-leukemic effect through the generation of ROS and induction of ER stress in leukemia cell lines.
Preclinical • Journal
|
HMOX1 (Heme Oxygenase 1) • ATF4 (Activating Transcription Factor 4)
|
HMOX1 expression
|
VLX1570